Clinical Trials Sponsored by Keryx Biopharmaceuticals

Total 717 results

Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar

Hypertrophic Scar

China
HighTide Biopharma Pty Ltd
Shenzhen HighTide Biopharmaceutical Ltd.

Completed

A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise

Type 2 Diabetes Mellitus

China
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Completed

A Study of AK3280 in Chinese Healthy Volunteers

Healthy

China
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Beijing 302 Hospital

Unknown

Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer

Advanced Liver Cancer

China
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Zhejiang Cancer Hospital; Fudan University

Recruiting

IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Suzhou Kintor Pharmaceutical Inc,
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Recruiting

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

Solid Tumor

Taiwan
Sheba Medical Center
AbbVie Biopharmaceuticals LTD; Intel Electronics Ltd.

Completed

Assessment of Fluctuating Parkinson's Disease With Sensor-based Home Monitoring

Parkinson Disease

Israel
Icahn School of Medicine at Mount Sinai
Eiger BioPharmaceuticals

Withdrawn

Interferon Lambda Therapy for COVID-19

SARS-CoV-2
AskGene Pharma, Inc.
Suzhou Aosaikang Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of ASKG712 in Patients With Diabetic Macular Edema

Diabetic Macular Edema

China
AskGene Pharma, Inc.
Suzhou Aosaikang Biopharmaceutical Co., Ltd.

Recruiting

A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

China
Taipei City Hospital
The One Biopharmaceutical Co., Ltd.

Completed

Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors

Non-alcoholic Fatty Liver Disease | Liver Fibrosis | Liver Injury

Taiwan
Conjupro Biotherapeutics, Inc.
CSPC Megalith Biopharmaceutical Co., Ltd.

Withdrawn

Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers

Gastric Cancer | Pancreatic Cancer
Beijing Tsinghua Chang Gung Hospital
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Recruiting

Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation

Hepatocellular Carcinoma

China
Kim, Seok Jin
Celltrion; Samyang Biopharmaceuticals Corporation

Recruiting

Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL. (Lemon-C)

Primary CNS Lymphoma

Korea, Republic of
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Defengrei Biotechnology Co.,Ltd

Completed

Safety and Tolerability of BDB-001 Injection in Healthy Subjects

Healthy

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Defengrei Biotechnology Co.,Ltd

Completed

Tolerability and Safety of BDB-001 Injection in Healthy Subjects

Healthy

China
Shanghai Ark Biopharmaceutical Co., Ltd.
Ark Biosciences Pty Ltd.

Completed

Viral Inhibition in Children for Treatment of RSV (VICTOR)

RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Australia, Hong Kong, Israel, Lebanon, Malaysia, Poland, Taiwan, Turkey
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer

Advanced Gastric Cancer

China
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

Advanced Breast Cancer

China
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Beijing Friendship Hospital

Unknown

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome

Hemophagocytic Syndrome

China
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Shenzhen Second People's Hospital

Unknown

Targeted T-cell Therapy in Solid Tumors

Malignant Solid Tumor

China
Nanfang Hospital, Southern Medical University
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

Neoplasms | Respiratory Tract Diseases | Lung Diseases | Neoplasms by Site | Lung Neoplasms | Small Cell Lung Carcinoma | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms

China
Day One Biopharmaceuticals, Inc.
SIOPe Brain Tumor Group LOGGIC Consortium

Recruiting

DAY101 vs. Standard of Care Chemotherapy in Pediatric Patients With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Low-grade Glioma

United States, Korea, Republic of, France, Germany, Spain, United Kingdom, Belgium, Denmark, Canada, Italy, Finland, Australia, Ireland, Switzerland, Netherlands, Czechia, Greece, New Zealand, Slovenia, Sweden, Hungary, Singapore, A... and more
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Defengrui Biotechnology Co. Ltd

Terminated

Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS

COVID-19 Pneumonia

Spain, Bangladesh, China, India, Indonesia
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Defengrui Biotechnology Co. Ltd

Terminated

A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients

COVID-19

China
Hillhurst Biopharmaceuticals, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers

Anemia, Sickle Cell

United States
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Sunshine Lake Pharma Co., Ltd.

Terminated

KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma

Advanced HCC

China
Hillhurst Biopharmaceuticals, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)

Anemia, Sickle Cell

United States
Peking Union Medical College Hospital
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Not yet recruiting

Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Institute of Hematology & Blood Diseases Hospital

Recruiting

A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Acute Myeloid Leukemia | Myelodysplastic Syndromes

China
Cardresearch
McMaster University; Eiger BioPharmaceuticals; Cytel Inc.; Fastgrants; RainWater...

Recruiting

Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms

Covid19 | SARS-Associated Coronavirus

Brazil
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.
Peking University People's Hospital

Completed

To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients

Cirrhosis | Chronic Hepatics C Virus (HCV) Genotype 1 | Non-Cirrhotic | Treatment naïve

China
Yale University
National Institute on Drug Abuse (NIDA); Nabi Biopharmaceuticals

Completed

Nicotine Vaccination and Nicotinic Receptor Occupancy

Nicotine Dependence

United States
Klus Pharma Inc.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Recruiting

A Study of SKB264 for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
China Resources Biopharmaceutical Co., Ltd
Peking University Third Hospital

Recruiting

A Trial of CRB4101 in Healthy Subjects

Healthy Adult Subjects

China
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer

Advanced Liver Cancer

China
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer

Advanced Colorectal Cancer

China
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Advanced Kidney Cancer

China
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer

Advanced Lung Cancer

China
Fuda Cancer Hospital, Guangzhou
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Withdrawn

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer

Advanced Pancreatic Cancer

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Sanuo Jiayi Biotechnology Co. LTD

Terminated

Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B

Chronic Hepatitis b

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Sanuo Jiayi Biotechnology Co. LTD

Terminated

To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B

Chronic Hepatitis b

China
Boston Children's Hospital
Merck Sharp & Dohme LLC; Schering-Plough; Eiger BioPharmaceuticals

Active, not recruiting

Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

Progeria

United States
Massachusetts General Hospital
Navidea Biopharmaceuticals; Havard University Center for AIDS Research

Completed

Use of 99mTc Tilmanocept for Imaging Arterial Inflammation

HIV

United States
Navidea Biopharmaceuticals
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.

Liver Metastases | Colorectal Carcinoma

United States
Navidea Biopharmaceuticals
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)

HIV Infections | Kaposi Sarcoma

United States
Suzhou Connect Biopharmaceuticals, Ltd.
Tigermed Consulting Co., Ltd; Nucleus Network Ltd

Completed

Phase 1 Study Accessing the Safety and Tolerability of CBP-307

Autoimmune Diseases

Australia
Shanghai Belief-Delivery BioMed Co., Ltd
Shanghai MYGT Biopharmaceutical LLC

Recruiting

Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs

Hemophilia A

China
Chongqing University Cancer Hospital
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Recruiting

Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells

Lymphoma

China

Clinical Trials Sponsored by Keryx Biopharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations